Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice

European Journal of Pharmacology

Volumn 552, Issue 1-3, 2006, Pages 99-104

  Nozaki, Chihiro ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Opioid receptor; 5 HT; Chronic pain; Fluvoxamine; Sciatic nerve ligation

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; FLUVOXAMINE; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; MALE; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; TREATMENT OUTCOME;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUVOXAMINE; HYPERALGESIA; INJECTIONS, SPINAL; KETANSERIN; MALE; MICE; MICE, INBRED ICR; NALOXONE; NEURALGIA; ONDANSETRON; RECEPTORS, OPIOID; SCIATIC NERVE; SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 33750470836     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.029     Document Type: Article

References (28)

1. 1/2 receptors in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 497 (2004) 285-292
2. Atkinson J.H., Slater M.A., Wahlgren D.R., Williams R.A., Zisook S., Pruitt S.D., Epping-Jordan J.E., Patterson T.L., Grant I., Abramson I., and Garfin S.R. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 83 (1999) 137-145
3. Bardin L., Lavarenne J., and Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 86 (2000) 11-18
4. Coquoz D., Porchet H.C., and Dayer P. Central analgesic effects of desipramine, fluvoxamine and moclobemide after single oral dosing: a study in healthy volunteers. Clin. Pharmacol. Ther. 54 (1993) 339-344
5. Duman E.N., Kesim M., Kadioglu M., Yaris E., Kalyoncu N.I., and Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J. Pharm. Sci. 94 (2004) 161-165
6. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain 23 (1985) 1-8
7. Fields H.L., Heinricher M.M., and Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14 (1991) 219-245
8. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med. 1 (2000) 310-316
9. 3 receptors modulate spinal nociceptive reflexes. Brain Res. 510 (1990) 12-16
10. Gray A.M., Spencer P.S.J., and Sewell R.D.E. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br. J. Pharmacol. 124 (1998) 669-674
11. 2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?. Eur. J. Pharmacol. 378 (1999) 161-168
12. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
13. Jung A.C., Staiger T., and Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J. Gen. Intern. Med. 12 (1997) 384-389
14. 3 receptors on antinociceptive effect of paroxetine in chemical stimuli in mice. J. Pharm. Sci. 97 (2005) 61-66
15. 3 receptor in the rat central nervous system are mainly located on nerve fibers and terminals. Brain Res. 612 (1993) 289-298
16. Korzeniewska-Rybicka I., and Plaznik A. Analgesic effect of antidepressant drugs. Pharmacol. Biochem. Behav. 59 (1998) 331-338
17. Marchand F., Ardid D., Chapuy E., Alloui A., Jourdan D., and Eschalier A. Evidence for an involvement of Supraspinal δ- and spinal μ-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J. Pharmacol. Exp. Ther. 307 (2003) 268-274
18. 2 receptor in the rat spinal cord. Brain Res. 550 (1991) 15-23
19. Narita M., Narita M., Kaneko C., Miyoshi K., Nagumo Y., Kuzumaki N., Nakajima M., Nanjo K., Matsuzawa K., Yamazaki M., and Suzuki T. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31 (2005) 739-750
20. Obata H., Saito S., Sasaki M., Ishizaki K., and Goto F. Antiallodynic effect of intrathecally administered 5-HT2 agonists in rats with nerve ligation. Pain 90 (2001) 173-179
21. 3 receptors. Brain Res. 845 (1999) 130-138
22. Sawynok J., Esser M.J., and Reid A.R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82 (1999) 149-158
23. Schreiber S., Backer M.M., Yanai J., and Pick C.G. The antinociceptive effect of fluvoxamine. Eur. Neuropsychopharmacol. 6 (1996) 281-284
24. Schreiber S., Backer M.M., and Pick C.G. The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci. Lett. 273 (1999) 85-88
25. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
26. Singh V.P., Jain N.K., and Kulkarni S.K. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res. 915 (2001) 218-226
27. Xu W., Qiu X.C., and Han J.S. Serotonin receptor subtypes in spinal antinociception in the rat. J. Pharmacol. Exp. Ther. 269 (1994) 1182-1189
28. Yaksh T.L., and Wilson P.R. Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 208 (1979) 446-453